Detalhe da pesquisa
1.
A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo.
J Lipid Res
; 52(1): 78-86, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20959675
2.
Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents.
J Gerontol A Biol Sci Med Sci
; 68(10): 1181-92, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23525481
3.
An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes.
Int J Biol Sci
; 8(3): 310-27, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22355267
4.
Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors.
PLoS One
; 5(2): e9094, 2010 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20161710
5.
IgG2m4, an engineered antibody isotype with reduced Fc function.
MAbs
; 1(6): 572-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-20073128